
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (18): 2285-2293.DOI: 10.12114/j.issn.1007-9572.2024.0222
Special Issue: 共病最新文章合辑; 心血管最新文章合辑; 肥胖/减重最新文章合辑
• Article·Cardiovascular and Metabolic Comorbidities Section • Previous Articles Next Articles
Received:2024-06-10
Revised:2024-10-10
Published:2025-06-20
Online:2025-04-25
Contact:
WANG Weiqiang
通讯作者:
王为强
作者简介:作者贡献:
潘姚佳、傅方琳、韩正、孙梦、顾怀聪负责试验的实施、实施数据的收集;潘姚佳、顾怀聪负责整理数据;潘姚佳负责分析数据、论文撰写;王为强负责试验研究规划及监督、论文质量审校及指导、经费支持,对论文负责;潘姚佳、傅方琳负责论文润色及修改。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0222
| 特征 | 男性 | 女性 | 总人群 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 非共病(n=22 281) | 共病(n=4 445) | χ2(Z)值 | P值 | 非共病(n=38 170) | 共病(n=5 916) | χ2(Z)值 | P值 | 非共病(n=60 451) | 共病(n=10 361) | χ2(Z)值 | P值 | |
| 在婚[例(%)] | 20 927(93.9) | 4 164(93.7) | 0.387 | 0.534 | 35 243(92.3) | 5 413(91.5) | 4.966 | 0.026 | 56 170(92.9) | 9 577(92.4) | 3.134 | 0.077 |
| 高中及以上学历[例(%)] | 3 494(15.7) | 984(22.1) | 110.727 | <0.001 | 3 044(8.0) | 436(7.4) | 2.579 | 0.108 | 6 538(10.8) | 1 420(13.7) | 74.051 | <0.001 |
| 农民[例(%)] | 13 263(59.5) | 2 257(50.8) | 116.521 | <0.001 | 24 125(63.2) | 3 824(64.6) | 4.540 | 0.033 | 37 388(61.8) | 6 081(58.7) | 37.195 | <0.001 |
| 吸烟[例(%)] | 10 533(47.3) | 2 127(47.9) | 0.497 | 0.481 | 521(1.4) | 111(1.9) | 9.477 | 0.002 | 11 054(18.3) | 2 238(21.6) | 63.723 | <0.001 |
| 饮酒[例(%)] | 7 268(32.6) | 1 549(34.8) | 8.324 | 0.004 | 1 307(3.4) | 166(2.8) | 6.061 | 0.014 | 8 575(14.2) | 1 715(16.6) | 39.915 | <0.001 |
| 年龄[M(QR),岁] | 54.0(10.0) | 56.0(10.0) | 12.403a | <0.001 | 53.0(8.0) | 56.0(8.0) | 31.874a | <0.001 | 54.0(9.0) | 56.0(9.0) | 32.620a | <0.001 |
| FBG[M(QR),mmol/L] | 5.70(1.14) | 6.40(2.30) | 38.514a | <0.001 | 5.60(1.20) | 6.40(2.40) | 46.012a | <0.001 | 5.60(1.20) | 6.40(2.40) | 60.344a | <0.001 |
| TG[M(QR),mmol/L] | 1.26(0.83) | 2.06(1.53) | 46.065a | <0.001 | 1.34(0.80) | 2.25(1.38) | 59.592a | <0.001 | 1.31(0.82) | 2.17(1.45) | 74.600a | <0.001 |
| TyG[M(QR)] | 8.67(0.70) | 9.29(0.81) | 55.643a | <0.001 | 8.72(0.66) | 9.34(0.72) | 71.337a | <0.001 | 8.70(0.67) | 9.32(0.76) | 90.000a | <0.001 |
| BMI[M(QR),kg/m2] | 24.30(3.73) | 26.17(4.00) | 35.242a | <0.001 | 24.29(4.14) | 25.92(4.59) | 33.903a | <0.001 | 24.29(3.97) | 26.03(4.38) | 48.446a | <0.001 |
| TC[M(QR),mmol/L] | 4.28(1.19) | 4.37(1.56) | 7.044a | <0.001 | 4.63(1.26) | 5.06(1.90) | 26.988a | <0.001 | 4.49(1.25) | 4.77(1.79) | 22.602a | <0.001 |
| HDL-C[M(QR),mmol/L] | 1.36(0.50) | 1.10(0.41) | 41.533a | <0.001 | 1.50(0.52) | 1.33(0.52) | 30.568a | <0.001 | 1.45(0.52) | 1.23(0.51) | 51.037a | <0.001 |
| LDL-C[M(QR),mmol/L] | 2.27(1.05) | 2.24(1.29) | 1.053a | 0.293 | 2.46(1.09) | 2.66(1.61) | 17.042a | <0.001 | 2.39(1.09) | 2.47(1.49) | 12.104a | <0.001 |
| 肥胖类型[例(%)] | 1 190.460 | <0.001 | 1 129.644 | <0.001 | 2 249.081 | <0.001 | ||||||
| 非肥胖 | 9 322(41.8) | 855(19.2) | 15 426(40.4) | 1 308(22.1) | 24 748(40.9) | 2 163(20.9) | ||||||
| 外周型肥胖 | 5 735(25.7) | 1 033(23.2) | 7 898(20.7) | 1 018(17.2) | 13 633(22.6) | 2 051(19.8) | ||||||
| 中心型肥胖 | 664(3.0) | 142(3.2) | 1 892(5.0) | 307(5.2) | 2 556(4.2) | 449(4.3) | ||||||
| 复合型肥胖 | 6 560(29.4) | 2 415(54.3) | 12 954(33.9) | 3 283(55.5) | 19 514(32.3) | 5 698(55.0) | ||||||
Table 1 General information and prevalence of CMM in different populations
| 特征 | 男性 | 女性 | 总人群 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 非共病(n=22 281) | 共病(n=4 445) | χ2(Z)值 | P值 | 非共病(n=38 170) | 共病(n=5 916) | χ2(Z)值 | P值 | 非共病(n=60 451) | 共病(n=10 361) | χ2(Z)值 | P值 | |
| 在婚[例(%)] | 20 927(93.9) | 4 164(93.7) | 0.387 | 0.534 | 35 243(92.3) | 5 413(91.5) | 4.966 | 0.026 | 56 170(92.9) | 9 577(92.4) | 3.134 | 0.077 |
| 高中及以上学历[例(%)] | 3 494(15.7) | 984(22.1) | 110.727 | <0.001 | 3 044(8.0) | 436(7.4) | 2.579 | 0.108 | 6 538(10.8) | 1 420(13.7) | 74.051 | <0.001 |
| 农民[例(%)] | 13 263(59.5) | 2 257(50.8) | 116.521 | <0.001 | 24 125(63.2) | 3 824(64.6) | 4.540 | 0.033 | 37 388(61.8) | 6 081(58.7) | 37.195 | <0.001 |
| 吸烟[例(%)] | 10 533(47.3) | 2 127(47.9) | 0.497 | 0.481 | 521(1.4) | 111(1.9) | 9.477 | 0.002 | 11 054(18.3) | 2 238(21.6) | 63.723 | <0.001 |
| 饮酒[例(%)] | 7 268(32.6) | 1 549(34.8) | 8.324 | 0.004 | 1 307(3.4) | 166(2.8) | 6.061 | 0.014 | 8 575(14.2) | 1 715(16.6) | 39.915 | <0.001 |
| 年龄[M(QR),岁] | 54.0(10.0) | 56.0(10.0) | 12.403a | <0.001 | 53.0(8.0) | 56.0(8.0) | 31.874a | <0.001 | 54.0(9.0) | 56.0(9.0) | 32.620a | <0.001 |
| FBG[M(QR),mmol/L] | 5.70(1.14) | 6.40(2.30) | 38.514a | <0.001 | 5.60(1.20) | 6.40(2.40) | 46.012a | <0.001 | 5.60(1.20) | 6.40(2.40) | 60.344a | <0.001 |
| TG[M(QR),mmol/L] | 1.26(0.83) | 2.06(1.53) | 46.065a | <0.001 | 1.34(0.80) | 2.25(1.38) | 59.592a | <0.001 | 1.31(0.82) | 2.17(1.45) | 74.600a | <0.001 |
| TyG[M(QR)] | 8.67(0.70) | 9.29(0.81) | 55.643a | <0.001 | 8.72(0.66) | 9.34(0.72) | 71.337a | <0.001 | 8.70(0.67) | 9.32(0.76) | 90.000a | <0.001 |
| BMI[M(QR),kg/m2] | 24.30(3.73) | 26.17(4.00) | 35.242a | <0.001 | 24.29(4.14) | 25.92(4.59) | 33.903a | <0.001 | 24.29(3.97) | 26.03(4.38) | 48.446a | <0.001 |
| TC[M(QR),mmol/L] | 4.28(1.19) | 4.37(1.56) | 7.044a | <0.001 | 4.63(1.26) | 5.06(1.90) | 26.988a | <0.001 | 4.49(1.25) | 4.77(1.79) | 22.602a | <0.001 |
| HDL-C[M(QR),mmol/L] | 1.36(0.50) | 1.10(0.41) | 41.533a | <0.001 | 1.50(0.52) | 1.33(0.52) | 30.568a | <0.001 | 1.45(0.52) | 1.23(0.51) | 51.037a | <0.001 |
| LDL-C[M(QR),mmol/L] | 2.27(1.05) | 2.24(1.29) | 1.053a | 0.293 | 2.46(1.09) | 2.66(1.61) | 17.042a | <0.001 | 2.39(1.09) | 2.47(1.49) | 12.104a | <0.001 |
| 肥胖类型[例(%)] | 1 190.460 | <0.001 | 1 129.644 | <0.001 | 2 249.081 | <0.001 | ||||||
| 非肥胖 | 9 322(41.8) | 855(19.2) | 15 426(40.4) | 1 308(22.1) | 24 748(40.9) | 2 163(20.9) | ||||||
| 外周型肥胖 | 5 735(25.7) | 1 033(23.2) | 7 898(20.7) | 1 018(17.2) | 13 633(22.6) | 2 051(19.8) | ||||||
| 中心型肥胖 | 664(3.0) | 142(3.2) | 1 892(5.0) | 307(5.2) | 2 556(4.2) | 449(4.3) | ||||||
| 复合型肥胖 | 6 560(29.4) | 2 415(54.3) | 12 954(33.9) | 3 283(55.5) | 19 514(32.3) | 5 698(55.0) | ||||||
| 项目 | 非肥胖亚组(n=26 911) | 外周型肥亚组(n=15 684) | 中心性肥胖亚组(n=3 005) | 复合型肥胖亚组(n=25 212) | χ2(Z)值 | P值 |
|---|---|---|---|---|---|---|
| 在婚[例(%)] | 25 003(92.9) | 14 659(93.5) | 2 757(91.7)b | 23 328(92.5)b | 18.524 | <0.001 |
| 高中及以上学历[例(%)] | 3 339(12.4) | 1 913(12.2) | 296(9.9)ab | 2 410(9.6)ab | 128.424 | <0.001 |
| 农民[例(%)] | 16 096(59.8) | 9 283(59.2) | 1 943(64.7)ab | 16 147(64.0)ab | 148.880 | <0.001 |
| 吸烟[例(%)] | 5 378(20.0) | 3 088(19.7) | 418(13.9)ab | 4 408(17.5)abc | 108.618 | <0.001 |
| 饮酒[例(%)] | 3 709(13.8) | 2 406(15.3)a | 342(11.4)ab | 3 833(15.2)ac | 53.592 | <0.001 |
| 高血压[例(%)] | 4 660(17.3) | 3 985(25.4)a | 773(25.7)a | 9 669(38.4)abc | 2 954.106 | <0.001 |
| 糖尿病[例(%)] | 1 434(5.3) | 1 008(6.4)a | 278(9.3)ab | 2 817(11.2)abc | 675.805 | <0.001 |
| 冠心病[例(%)] | 109(0.4) | 88(0.6) | 15(0.5) | 198(0.8)ab | 33.215 | <0.001 |
| 脑卒中[例(%)] | 511(1.9) | 382(2.4)a | 73(2.4) | 793(3.1)ab | 83.748 | <0.001 |
| 血脂异常[例(%)] | 5 858(28.1) | 4 635(22.2)a | 958(4.6)a | 9 423(45.1)abc | 1 534.222 | <0.001 |
| 年龄[M(QR),岁] | 54.0(9.0) | 53.0(10.0)a | 55.0(10.0)ab | 54.0(9.0)abc | 290.407d | <0.001 |
| TG[M(QR),mmol/L] | 1.22(0.78) | 1.40(0.93)a | 1.38(0.97)a | 1.58(1.05)abc | 3 123.340d | <0.001 |
| TyG指数 | 8.62(0.68) | 8.77(0.72)a | 8.78(0.75)a | 8.94(0.75)abc | 4 281.164d | <0.001 |
| BMI[M(QR),kg/m2] | 22.19(2.13) | 25.21(2.70)a | 23.11(1.22)ab | 27.36(3.36)abc | 55 356.957d | <0.001 |
| TC[M(QR),mmol/L] | 4.47(1.29) | 4.52(1.29)a | 4.56(1.33)a | 4.58(1.36)ab | 144.250d | <0.001 |
| HDL-C[M(QR),mmol/L] | 1.53(0.58) | 1.40(0.51)a | 1.42(0.53)a | 1.33(0.46)abc | 3 116.014d | <0.001 |
| LDL-C[M(QR),mmol/L] | 2.33(1.10) | 2.42(1.12)a | 2.43(1.19)a | 2.44(1.16)ab | 214.088d | <0.001 |
| 性别[例(%)] | 397.257 | <0.001 | ||||
| 男 | 10 177(37.8) | 6 768(43.2)a | 806(26.8)ab | 8 975(35.6)abc | ||
| 女 | 16 734(62.2) | 8 916(56.8)a | 2 199(73.2)ab | 16 237(64.4)abc | ||
| CMD患病种数[例(%)] | 4 262.895 | <0.001 | ||||
| 0种 | 16 811(62.5) | 7 967(50.8)a | 1 435(47.8)ab | 9 143(36.3)abc | ||
| 1种 | 7 937(29.5) | 5 666(36.1)a | 1 121(37.3)a | 10 371(41.1)abc | ||
| 2种 | 1 875(7.0) | 1 740(11.1)a | 379(12.6)a | 4 635(18.4)abc | ||
| 3种 | 268(1.0) | 294(1.9)a | 63(2.1)a | 995(3.9)abc | ||
| 4种 | 19(0.1) | 15(0.1) | 6(0.2) | 66(0.3)ab | ||
| 5种 | 1(0.0) | 2(0.0) | 1(0.0) | 2(0.0) |
Table 2 Comparison of general information and CMM prevalence among middle aged residents with different obesity types in Anhui Province
| 项目 | 非肥胖亚组(n=26 911) | 外周型肥亚组(n=15 684) | 中心性肥胖亚组(n=3 005) | 复合型肥胖亚组(n=25 212) | χ2(Z)值 | P值 |
|---|---|---|---|---|---|---|
| 在婚[例(%)] | 25 003(92.9) | 14 659(93.5) | 2 757(91.7)b | 23 328(92.5)b | 18.524 | <0.001 |
| 高中及以上学历[例(%)] | 3 339(12.4) | 1 913(12.2) | 296(9.9)ab | 2 410(9.6)ab | 128.424 | <0.001 |
| 农民[例(%)] | 16 096(59.8) | 9 283(59.2) | 1 943(64.7)ab | 16 147(64.0)ab | 148.880 | <0.001 |
| 吸烟[例(%)] | 5 378(20.0) | 3 088(19.7) | 418(13.9)ab | 4 408(17.5)abc | 108.618 | <0.001 |
| 饮酒[例(%)] | 3 709(13.8) | 2 406(15.3)a | 342(11.4)ab | 3 833(15.2)ac | 53.592 | <0.001 |
| 高血压[例(%)] | 4 660(17.3) | 3 985(25.4)a | 773(25.7)a | 9 669(38.4)abc | 2 954.106 | <0.001 |
| 糖尿病[例(%)] | 1 434(5.3) | 1 008(6.4)a | 278(9.3)ab | 2 817(11.2)abc | 675.805 | <0.001 |
| 冠心病[例(%)] | 109(0.4) | 88(0.6) | 15(0.5) | 198(0.8)ab | 33.215 | <0.001 |
| 脑卒中[例(%)] | 511(1.9) | 382(2.4)a | 73(2.4) | 793(3.1)ab | 83.748 | <0.001 |
| 血脂异常[例(%)] | 5 858(28.1) | 4 635(22.2)a | 958(4.6)a | 9 423(45.1)abc | 1 534.222 | <0.001 |
| 年龄[M(QR),岁] | 54.0(9.0) | 53.0(10.0)a | 55.0(10.0)ab | 54.0(9.0)abc | 290.407d | <0.001 |
| TG[M(QR),mmol/L] | 1.22(0.78) | 1.40(0.93)a | 1.38(0.97)a | 1.58(1.05)abc | 3 123.340d | <0.001 |
| TyG指数 | 8.62(0.68) | 8.77(0.72)a | 8.78(0.75)a | 8.94(0.75)abc | 4 281.164d | <0.001 |
| BMI[M(QR),kg/m2] | 22.19(2.13) | 25.21(2.70)a | 23.11(1.22)ab | 27.36(3.36)abc | 55 356.957d | <0.001 |
| TC[M(QR),mmol/L] | 4.47(1.29) | 4.52(1.29)a | 4.56(1.33)a | 4.58(1.36)ab | 144.250d | <0.001 |
| HDL-C[M(QR),mmol/L] | 1.53(0.58) | 1.40(0.51)a | 1.42(0.53)a | 1.33(0.46)abc | 3 116.014d | <0.001 |
| LDL-C[M(QR),mmol/L] | 2.33(1.10) | 2.42(1.12)a | 2.43(1.19)a | 2.44(1.16)ab | 214.088d | <0.001 |
| 性别[例(%)] | 397.257 | <0.001 | ||||
| 男 | 10 177(37.8) | 6 768(43.2)a | 806(26.8)ab | 8 975(35.6)abc | ||
| 女 | 16 734(62.2) | 8 916(56.8)a | 2 199(73.2)ab | 16 237(64.4)abc | ||
| CMD患病种数[例(%)] | 4 262.895 | <0.001 | ||||
| 0种 | 16 811(62.5) | 7 967(50.8)a | 1 435(47.8)ab | 9 143(36.3)abc | ||
| 1种 | 7 937(29.5) | 5 666(36.1)a | 1 121(37.3)a | 10 371(41.1)abc | ||
| 2种 | 1 875(7.0) | 1 740(11.1)a | 379(12.6)a | 4 635(18.4)abc | ||
| 3种 | 268(1.0) | 294(1.9)a | 63(2.1)a | 995(3.9)abc | ||
| 4种 | 19(0.1) | 15(0.1) | 6(0.2) | 66(0.3)ab | ||
| 5种 | 1(0.0) | 2(0.0) | 1(0.0) | 2(0.0) |
| 变量 | 赋值 | 变量 | 赋值 |
|---|---|---|---|
| 年龄(岁) | 连续变量 | 高血压合并糖尿病 | 否=1,是=2 |
| 性别 | 男性=1,女性=2 | 高血压合并血脂异常 | 否=1,是=2 |
| 在婚 | 否=0,是=1 | 糖尿病合并血脂异常 | 否=1,是=2 |
| 高中及以上学历 | 否=0,是=1 | 未患CMD | 否=0,是=1 |
| 农民 | 否=0,是=1 | 患有1种CMD | 否=0,是=1 |
| 吸烟 | 否=0,是=1 | 患有2种CMD | 否=0,是=1 |
| 饮酒 | 否=0,是=1 | 患有3种CMD | 否=0,是=1 |
| 高血压 | 否=0,是=1 | 肥胖类型 | 非肥胖=1,外周型肥胖=2,中心型肥胖=3,复合型肥胖=4 |
| 糖尿病 | 否=0,是=1 | CMM | 否=1,是=2 |
| 血脂异常 | 否=0,是=1 |
Table 3 Logistic regression analysis identifying influencing factors for the risk of CMM in residents with different types of obesity
| 变量 | 赋值 | 变量 | 赋值 |
|---|---|---|---|
| 年龄(岁) | 连续变量 | 高血压合并糖尿病 | 否=1,是=2 |
| 性别 | 男性=1,女性=2 | 高血压合并血脂异常 | 否=1,是=2 |
| 在婚 | 否=0,是=1 | 糖尿病合并血脂异常 | 否=1,是=2 |
| 高中及以上学历 | 否=0,是=1 | 未患CMD | 否=0,是=1 |
| 农民 | 否=0,是=1 | 患有1种CMD | 否=0,是=1 |
| 吸烟 | 否=0,是=1 | 患有2种CMD | 否=0,是=1 |
| 饮酒 | 否=0,是=1 | 患有3种CMD | 否=0,是=1 |
| 高血压 | 否=0,是=1 | 肥胖类型 | 非肥胖=1,外周型肥胖=2,中心型肥胖=3,复合型肥胖=4 |
| 糖尿病 | 否=0,是=1 | CMM | 否=1,是=2 |
| 血脂异常 | 否=0,是=1 |
| 不同CMD的情况 | 分类 | 模型1 | 模型2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | 0R(95%CI) | P值 | β | SE | Wald χ2值 | 0R(95%CI) | P值 | ||
| 高血压(以非肥胖亚组为参照) | 外周型肥胖 | 0.486 | 0.024 | 396.995 | 1.626(1.550~1.706) | <0.001 | 0.528 | 0.025 | 451.378 | 1.696(1.615~1.781) | <0.001 |
| 中心型肥胖 | 0.503 | 0.045 | 126.426 | 1.654(1.515~1.805) | <0.001 | 0.453 | 0.046 | 99.098 | 1.573(1.439~1.720) | <0.001 | |
| 复合型肥胖 | 1.089 | 0.021 | 2 773.815 | 2.970(2.852~3.093) | <0.001 | 1.118 | 0.021 | 2 806.815 | 3.059(2.935~3.189) | <0.001 | |
| 糖尿病(以非肥胖亚组为参照) | 外周型肥胖 | 0.199 | 0.042 | 22.054 | 1.220(1.123~1.326) | <0.001 | 0.227 | 0.043 | 28.487 | 1.255(1.155~1.364) | <0.001 |
| 中心型肥胖 | 0.594 | 0.069 | 75.058 | 1.811(1.583~2.072) | <0.001 | 0.548 | 0.069 | 63.118 | 1.730(1.511~1.980) | <0.001 | |
| 复合型肥胖 | 0.804 | 0.034 | 569.110 | 2.235(2.092~2.387) | <0.001 | 0.815 | 0.034 | 577.655 | 2.259(2.114~2.415) | <0.001 | |
| 血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.411 | 0.023 | 321.350 | 1.508(1.441~1.577) | <0.001 | 0.418 | 0.023 | 330.041 | 1.519(1.452~1.589) | <0.001 |
| 中心型肥胖 | 0.520 | 0.042 | 154.436 | 1.682(1.550~1.826) | <0.001 | 0.548 | 0.042 | 169.839 | 1.730(1.593~1.879) | <0.001 | |
| 复合型肥胖 | 0.763 | 0.020 | 1 502.029 | 2.145(2.064~2.229) | <0.001 | 0.794 | 0.020 | 1 602.346 | 2.212(2.128~2.300) | <0.001 | |
| 高血压合并糖尿病(以非肥胖亚组为参照) | 外周型肥胖 | 0.498 | 0.063 | 61.581 | 1.645(1.453~1.862) | <0.001 | 0.534 | 0.064 | 70.366 | 1.705(1.505~1.932) | <0.001 |
| 中心型肥胖 | 0.883 | 0.098 | 81.825 | 2.419(1.998~2.930) | <0.001 | 0.820 | 0.098 | 69.786 | 2.271(1.873~2.753) | <0.001 | |
| 复合型肥胖 | 1.280 | 0.051 | 634.740 | 3.595(3.254~3.971) | <0.001 | 1.293 | 0.051 | 642.058 | 3.645(3.298~4.029) | <0.001 | |
| 高血压合并血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.658 | 0.041 | 263.288 | 1.932(1.784~2.092) | <0.001 | 0.679 | 0.041 | 278.167 | 1.973(1.821~2.137) | <0.001 |
| 中心型肥胖 | 0.641 | 0.072 | 80.270 | 1.899(1.650~2.185) | <0.001 | 0.625 | 0.072 | 75.538 | 1.868(1.623~2.151) | <0.001 | |
| 复合型肥胖 | 1.310 | 0.034 | 1 501.144 | 3.705(3.468~3.959) | <0.001 | 1.331 | .034 | 1 532.780 | 3.784(3.540~4.045) | <0.001 | |
| 糖尿病合并血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.472 | 0.071 | 44.672 | 1.602(1.395~1.840) | <0.001 | 0.495 | 0.071 | 49.060 | 1.640(1.428~1.884) | <0.001 |
| 中心型肥胖 | 0.885 | 0.108 | 67.695 | 2.423(1.963~2.992) | <0.001 | 0.869 | 0.108 | 64.743 | 2.383(1.929~2.945) | <0.001 | |
| 复合型肥胖 | 1.144 | 0.057 | 403.614 | 3.140(2.809~3.511) | <0.001 | 1.167 | 0.057 | 417.047 | 3.211(2.871~3.592) | <0.001 | |
| 未患CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.478 | 0.020 | 551.544 | 1.612(1.549~1.678) | <0.001 | 0.510 | 0.021 | 611.322 | 1.665(1.599~1.734) | <0.001 |
| 中心型肥胖 | 0.599 | 0.039 | 240.763 | 1.821(1.688~1.964) | <0.001 | 0.581 | 0.039 | 220.593 | 1.788(1.656~1.930) | <0.001 | |
| 复合型肥胖 | 1.073 | 0.018 | 3 490.432 | 2.925(2.823~3.031) | <0.001 | 1.105 | 0.018 | 3 585.453 | 3.020(2.913~3.131) | <0.001 | |
| 患1种CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.302 | 0.021 | 199.960 | 1.352(1.297~1.410) | <0.001 | 0.310 | 0.021 | 210.256 | 1.363(1.308~1.422) | <0.001 |
| 中心型肥胖 | 0.352 | 0.040 | 77.523 | 1.422(1.315~1.538) | <0.001 | 0.345 | 0.040 | 73.765 | 1.412(1.305~1.527) | <0.001 | |
| 复合型肥胖 | 0.513 | 0.019 | 768.839 | 1.671(1.611~1.732) | <0.001 | 0.520 | 0.019 | 782.318 | 1.681(1.621~1.744) | <0.001 | |
| 患2种CMD(以非肥胖组为参照) | 外周型肥胖 | 0.516 | 0.035 | 213.702 | 1.666(1.556~1.784) | <0.001 | 0.537 | 0.035 | 233.923 | 1.721(1.598~1.834) | <0.001 |
| 中心型肥胖 | 0.656 | 0.060 | 119.793 | 1.927(1.714~2.167) | <0.001 | 0.626 | 0.060 | 107.499 | 1.870(1.661~2.105) | <0.001 | |
| 复合型肥胖 | 1.101 | 0.029 | 1 447.633 | 3.008(2.842~3.183) | <0.001 | 1.121 | 0.029 | 1 476.690 | 3.068(2.897~3.248) | <0.001 | |
| 患3种CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.641 | 0.085 | 56.860 | 1.899(1.608~2.244) | <0.001 | 0.675 | 0.085 | 62.749 | 1.964(1.662~2.321) | <0.001 |
| 中心型肥胖 | 0.756 | 0.141 | 28.571 | 2.129(1.614~2.808) | <0.001 | 0.704 | 0.142 | 24.649 | 2.021(1.531~2.669) | <0.001 | |
| 复合型肥胖 | 1.407 | 0.069 | 411.258 | 4.085(3.565~4.680) | <0.001 | 1.425 | 0.070 | 419.137 | 4.158(3.628~4.766) | <0.001 | |
| 是否为CMM(以非肥胖亚组为参照) | 外周型肥胖 | 0.543 | 0.033 | 277.290 | 1.721(1.615~1.835) | <0.001 | 0.577 | 0.033 | 307.307 | 1.780(1.669~1.899) | <0.001 |
| 中心型肥胖 | 0.698 | 0.056 | 156.131 | 2.010(1.801~2.242) | <0.001 | 0.665 | 0.056 | 138.890 | 1.944(1.741~2.171) | <0.001 | |
| 复合型肥胖 | 1.206 | 0.027 | 1 994.582 | 3.341(3.169~3.522) | <0.001 | 1.236 | 0.027 | 2 047.441 | 3.441(3.262~3.630) | <0.001 | |
| TyG(以非肥胖亚组为参照) | 外周型肥胖 | 0.475 | 0.020 | 547.214 | 1.608(1.545~1.673) | <0.001 | 0.485 | 0.020 | 564.661 | 1.623(1.560~1.690) | <0.001 |
| 中心型肥胖 | 0.504 | 0.039 | 170.502 | 1.655(1.534~1.785) | <0.001 | 0.501 | 0.039 | 167.355 | 1.651(1.530~1.781) | <0.001 | |
| 复合型肥胖 | 0.978 | 0.018 | 2 932.076 | 2.659(2.566~2.754) | <0.001 | 0.996 | 0.018 | 3 002.676 | 2.708(2.613~2.806) | <0.001 | |
Figure 4 Logistic regression analysis identifying influencing factors for the risk of CMM in residents with different types of obesity
| 不同CMD的情况 | 分类 | 模型1 | 模型2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | 0R(95%CI) | P值 | β | SE | Wald χ2值 | 0R(95%CI) | P值 | ||
| 高血压(以非肥胖亚组为参照) | 外周型肥胖 | 0.486 | 0.024 | 396.995 | 1.626(1.550~1.706) | <0.001 | 0.528 | 0.025 | 451.378 | 1.696(1.615~1.781) | <0.001 |
| 中心型肥胖 | 0.503 | 0.045 | 126.426 | 1.654(1.515~1.805) | <0.001 | 0.453 | 0.046 | 99.098 | 1.573(1.439~1.720) | <0.001 | |
| 复合型肥胖 | 1.089 | 0.021 | 2 773.815 | 2.970(2.852~3.093) | <0.001 | 1.118 | 0.021 | 2 806.815 | 3.059(2.935~3.189) | <0.001 | |
| 糖尿病(以非肥胖亚组为参照) | 外周型肥胖 | 0.199 | 0.042 | 22.054 | 1.220(1.123~1.326) | <0.001 | 0.227 | 0.043 | 28.487 | 1.255(1.155~1.364) | <0.001 |
| 中心型肥胖 | 0.594 | 0.069 | 75.058 | 1.811(1.583~2.072) | <0.001 | 0.548 | 0.069 | 63.118 | 1.730(1.511~1.980) | <0.001 | |
| 复合型肥胖 | 0.804 | 0.034 | 569.110 | 2.235(2.092~2.387) | <0.001 | 0.815 | 0.034 | 577.655 | 2.259(2.114~2.415) | <0.001 | |
| 血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.411 | 0.023 | 321.350 | 1.508(1.441~1.577) | <0.001 | 0.418 | 0.023 | 330.041 | 1.519(1.452~1.589) | <0.001 |
| 中心型肥胖 | 0.520 | 0.042 | 154.436 | 1.682(1.550~1.826) | <0.001 | 0.548 | 0.042 | 169.839 | 1.730(1.593~1.879) | <0.001 | |
| 复合型肥胖 | 0.763 | 0.020 | 1 502.029 | 2.145(2.064~2.229) | <0.001 | 0.794 | 0.020 | 1 602.346 | 2.212(2.128~2.300) | <0.001 | |
| 高血压合并糖尿病(以非肥胖亚组为参照) | 外周型肥胖 | 0.498 | 0.063 | 61.581 | 1.645(1.453~1.862) | <0.001 | 0.534 | 0.064 | 70.366 | 1.705(1.505~1.932) | <0.001 |
| 中心型肥胖 | 0.883 | 0.098 | 81.825 | 2.419(1.998~2.930) | <0.001 | 0.820 | 0.098 | 69.786 | 2.271(1.873~2.753) | <0.001 | |
| 复合型肥胖 | 1.280 | 0.051 | 634.740 | 3.595(3.254~3.971) | <0.001 | 1.293 | 0.051 | 642.058 | 3.645(3.298~4.029) | <0.001 | |
| 高血压合并血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.658 | 0.041 | 263.288 | 1.932(1.784~2.092) | <0.001 | 0.679 | 0.041 | 278.167 | 1.973(1.821~2.137) | <0.001 |
| 中心型肥胖 | 0.641 | 0.072 | 80.270 | 1.899(1.650~2.185) | <0.001 | 0.625 | 0.072 | 75.538 | 1.868(1.623~2.151) | <0.001 | |
| 复合型肥胖 | 1.310 | 0.034 | 1 501.144 | 3.705(3.468~3.959) | <0.001 | 1.331 | .034 | 1 532.780 | 3.784(3.540~4.045) | <0.001 | |
| 糖尿病合并血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.472 | 0.071 | 44.672 | 1.602(1.395~1.840) | <0.001 | 0.495 | 0.071 | 49.060 | 1.640(1.428~1.884) | <0.001 |
| 中心型肥胖 | 0.885 | 0.108 | 67.695 | 2.423(1.963~2.992) | <0.001 | 0.869 | 0.108 | 64.743 | 2.383(1.929~2.945) | <0.001 | |
| 复合型肥胖 | 1.144 | 0.057 | 403.614 | 3.140(2.809~3.511) | <0.001 | 1.167 | 0.057 | 417.047 | 3.211(2.871~3.592) | <0.001 | |
| 未患CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.478 | 0.020 | 551.544 | 1.612(1.549~1.678) | <0.001 | 0.510 | 0.021 | 611.322 | 1.665(1.599~1.734) | <0.001 |
| 中心型肥胖 | 0.599 | 0.039 | 240.763 | 1.821(1.688~1.964) | <0.001 | 0.581 | 0.039 | 220.593 | 1.788(1.656~1.930) | <0.001 | |
| 复合型肥胖 | 1.073 | 0.018 | 3 490.432 | 2.925(2.823~3.031) | <0.001 | 1.105 | 0.018 | 3 585.453 | 3.020(2.913~3.131) | <0.001 | |
| 患1种CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.302 | 0.021 | 199.960 | 1.352(1.297~1.410) | <0.001 | 0.310 | 0.021 | 210.256 | 1.363(1.308~1.422) | <0.001 |
| 中心型肥胖 | 0.352 | 0.040 | 77.523 | 1.422(1.315~1.538) | <0.001 | 0.345 | 0.040 | 73.765 | 1.412(1.305~1.527) | <0.001 | |
| 复合型肥胖 | 0.513 | 0.019 | 768.839 | 1.671(1.611~1.732) | <0.001 | 0.520 | 0.019 | 782.318 | 1.681(1.621~1.744) | <0.001 | |
| 患2种CMD(以非肥胖组为参照) | 外周型肥胖 | 0.516 | 0.035 | 213.702 | 1.666(1.556~1.784) | <0.001 | 0.537 | 0.035 | 233.923 | 1.721(1.598~1.834) | <0.001 |
| 中心型肥胖 | 0.656 | 0.060 | 119.793 | 1.927(1.714~2.167) | <0.001 | 0.626 | 0.060 | 107.499 | 1.870(1.661~2.105) | <0.001 | |
| 复合型肥胖 | 1.101 | 0.029 | 1 447.633 | 3.008(2.842~3.183) | <0.001 | 1.121 | 0.029 | 1 476.690 | 3.068(2.897~3.248) | <0.001 | |
| 患3种CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.641 | 0.085 | 56.860 | 1.899(1.608~2.244) | <0.001 | 0.675 | 0.085 | 62.749 | 1.964(1.662~2.321) | <0.001 |
| 中心型肥胖 | 0.756 | 0.141 | 28.571 | 2.129(1.614~2.808) | <0.001 | 0.704 | 0.142 | 24.649 | 2.021(1.531~2.669) | <0.001 | |
| 复合型肥胖 | 1.407 | 0.069 | 411.258 | 4.085(3.565~4.680) | <0.001 | 1.425 | 0.070 | 419.137 | 4.158(3.628~4.766) | <0.001 | |
| 是否为CMM(以非肥胖亚组为参照) | 外周型肥胖 | 0.543 | 0.033 | 277.290 | 1.721(1.615~1.835) | <0.001 | 0.577 | 0.033 | 307.307 | 1.780(1.669~1.899) | <0.001 |
| 中心型肥胖 | 0.698 | 0.056 | 156.131 | 2.010(1.801~2.242) | <0.001 | 0.665 | 0.056 | 138.890 | 1.944(1.741~2.171) | <0.001 | |
| 复合型肥胖 | 1.206 | 0.027 | 1 994.582 | 3.341(3.169~3.522) | <0.001 | 1.236 | 0.027 | 2 047.441 | 3.441(3.262~3.630) | <0.001 | |
| TyG(以非肥胖亚组为参照) | 外周型肥胖 | 0.475 | 0.020 | 547.214 | 1.608(1.545~1.673) | <0.001 | 0.485 | 0.020 | 564.661 | 1.623(1.560~1.690) | <0.001 |
| 中心型肥胖 | 0.504 | 0.039 | 170.502 | 1.655(1.534~1.785) | <0.001 | 0.501 | 0.039 | 167.355 | 1.651(1.530~1.781) | <0.001 | |
| 复合型肥胖 | 0.978 | 0.018 | 2 932.076 | 2.659(2.566~2.754) | <0.001 | 0.996 | 0.018 | 3 002.676 | 2.708(2.613~2.806) | <0.001 | |
| 项目 | 男性 | 女性 | Z值 | P值 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | 0R(95%CI) | β | SE | Wald χ2值 | 0R(95%CI) | ||||
| 模型1 | 外周型肥胖 | 0.697 | 0.050 | 197.506 | 2.008(1.822~2.213)a | 0.454 | 0.044 | 104.134 | 1.574(1.443~1.717)a | 3.660 | <0.001 |
| 中心性肥胖 | 0.825 | 0.100 | 68.165 | 2.281(1.875~2.774)a | 0.546 | 0.069 | 63.158 | 1.727(1.509~1.976)a | 2.293 | 0.022 | |
| 复合型肥胖 | 1.420 | 0.043 | 1 067.342 | 4.137(3.799~4.504)a | 1.070 | 0.035 | 917.026 | 2.916(2.721~3.126)a | 6.243 | <0.001 | |
| 模型2 | 外周型肥胖 | 0.392 | 0.053 | 55.806 | 1.480(1.336~1.641)a | 0.293 | 0.047 | 38.869 | 1.340(1.222~1.469)a | 1.411 | 0.158 |
| 中心性肥胖 | 0.553 | 0.106 | 27.021 | 1.738(1.411~2.141)a | 0.363 | 0.073 | 24.599 | 1.437(1.245~1.658)a | 1.474 | 0.146 | |
| 复合型肥胖 | 0.924 | 0.046 | 395.335 | 2.519(2.300~2.760)a | 0.789 | 0.038 | 439.985 | 2.201(2.045~2.369)a | 2.258 | 0.024 | |
Table 5 Comparison of the risk of CMM among male and female residents with different types of obesity
| 项目 | 男性 | 女性 | Z值 | P值 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | 0R(95%CI) | β | SE | Wald χ2值 | 0R(95%CI) | ||||
| 模型1 | 外周型肥胖 | 0.697 | 0.050 | 197.506 | 2.008(1.822~2.213)a | 0.454 | 0.044 | 104.134 | 1.574(1.443~1.717)a | 3.660 | <0.001 |
| 中心性肥胖 | 0.825 | 0.100 | 68.165 | 2.281(1.875~2.774)a | 0.546 | 0.069 | 63.158 | 1.727(1.509~1.976)a | 2.293 | 0.022 | |
| 复合型肥胖 | 1.420 | 0.043 | 1 067.342 | 4.137(3.799~4.504)a | 1.070 | 0.035 | 917.026 | 2.916(2.721~3.126)a | 6.243 | <0.001 | |
| 模型2 | 外周型肥胖 | 0.392 | 0.053 | 55.806 | 1.480(1.336~1.641)a | 0.293 | 0.047 | 38.869 | 1.340(1.222~1.469)a | 1.411 | 0.158 |
| 中心性肥胖 | 0.553 | 0.106 | 27.021 | 1.738(1.411~2.141)a | 0.363 | 0.073 | 24.599 | 1.437(1.245~1.658)a | 1.474 | 0.146 | |
| 复合型肥胖 | 0.924 | 0.046 | 395.335 | 2.519(2.300~2.760)a | 0.789 | 0.038 | 439.985 | 2.201(2.045~2.369)a | 2.258 | 0.024 | |
| [1] |
蒋艳苹,罗玮,姚勇利,等. 西宁地区不同类型肥胖患者2型糖尿病患病情况分析[J]. 中国医药,2022,17(4):535-538. DOI:10.3969/j.issn.1006-6187.2017.03.010.
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
笃梦雪,吴楠,郎俊杰,等. 某校大学生不同肥胖类型与心血管疾病代谢指标的关系[J]. 中华疾病控制杂志,2021,25(11):1293-1296. DOI:10.16462/j.cnki.zhjbkz.2021.11.010.
|
| [6] |
陈祚,李苏宁,王馨,等. 我国中年人群高血压、超重和肥胖的发病率及其与心血管事件的关系[J]. 中华心血管病杂志,2020,48(1):47-53. DOI:10.3760/cma.j.issn.0253-3758.2020.01.005.
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
张海峰,靳迪,吕宪玉,等. 北京某三甲医院体检人群不同肥胖类型与骨密度及握力的相关性分析[J]. 解放军医学院学报,2020,41(7):666-669,674. DOI:10.3969/j.issn.2095-5227.2020.07.003.
|
| [12] | |
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
陈伟标,张艳,袁雪丽,等. 深圳市老年人"三高"共病现状及关联因素分析[J]. 中国慢性病预防与控制,2023,31(1):51-55. DOI:10.16386/j.cjpccd.issn.1004-6194.2023.01.012.
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
张迷磊,杨琼,陈海燕,等. 肥胖类型与壮族中老年居民心血管疾病危险因素发生及聚集情况的分析[J]. 广西医科大学学报,2023,40(9):1564-1569. DOI:10.16190/j.cnki.45-1211/r.2023.09.020.
|
| [25] |
徐肖倩,夏远,李海玲. 2015-2017年内蒙古自治区35~75岁居民中心型肥胖与心血管代谢性疾病和共病风险的关联研究[J]. 2024,39(6):776-780. DOI:10.3784/jbjc.202302060020.
|
| [26] |
傅方琳,潘姚佳,韩正,等. 不同性别老年人群身体圆度指数与体质量正常代谢异常表型的相关性研究:以三酰甘油葡萄糖乘积指数为潜在影响因素[J]. 中国全科医学,2024,27(30):3746-3752,3757.
|
| [27] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 中国循环杂志,2022,37(6):553-578. DOI:10.3969/j.issn.1000-3614.2022.06.001.
|
| [28] |
|
| [29] |
|
| [30] |
潘姚佳,王为强,易伟卓,等. 不同性别中年肥胖居民三酰甘油葡萄糖乘积指数与心血管疾病高危风险的关系研究[J]. 中国全科医学,2023,26(29):3628-3635. DOI:10.12114/j.issn.1007-9572.2022.0891. DOI:10.12114/j.issn.1007-9572.2022.0891.
|
| [31] |
|
| [32] |
姜博,方凯,韩雪玉,等. 北京市35~75岁居民心血管病高危人群特征[J]. 中华流行病学杂志,2022,43(3):366-372. DOI:10.3760/cma.j.cn112338-20210624-00493.
|
| [1] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [2] | ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765. |
| [3] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [4] | HUANG Haili, LI Yuhong, YU Yang, GUO Ping, HAN Changzheng, LIU Ping. A Mixed Study of Fertility Intention and Its Influencing Factors among the Childbearing-age Women in Anhui Province [J]. Chinese General Practice, 2026, 29(20): 2887-2894. |
| [5] | CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758. |
| [6] | WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774. |
| [7] | TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704. |
| [8] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [9] | LI Simin, ZHANG Tingting, WANG Kunbo, YANG Jianzhou, PING Weiwei. Effects of Exercise Dosage on Elderly Patients with Sarcopenia: a Meta-analysis [J]. Chinese General Practice, 2026, 29(17): 2400-2409. |
| [10] | Chinese Nutrition Society Obesity Prevention and Control Branch. Chinese Guidelines for Behavioral and Lifestyle Interventions for Obesity [J]. Chinese General Practice, 2026, 29(16): 2113-2139. |
| [11] | LI Jiali, LIU Fan, KE Lixin, LI Huijuan, WANG Haibo, ZHAO Xiaoxiao, ZHAO Xinke, LU Cuncun. Disease Burden of Obesity among Individuals Aged 60 and above Globally and in China from 1990 to 2021: Trend Analysis and Model-based Projection [J]. Chinese General Practice, 2026, 29(15): 2067-2076. |
| [12] | YANG Lei, GUAN Hua. Application Progress of Generative Artificial Intelligence in Weight Management [J]. Chinese General Practice, 2026, 29(12): 1533-1540. |
| [13] | HE Zhiguang, QIU Shanjiao, CHEN Zhang, LI Anchun, HUANG Wenjing. Interpretation and Discussion of the RACGP Guidelines for Preventive Activities in General Practice: Screening for Weight Issues and Preventive Strategies [J]. Chinese General Practice, 2026, 29(12): 1505-1510. |
| [14] | CHEN Xiaolong, JIN Jing, HUA Jialu, LI Yuyu, PAN Youjia, PAN Qi, TU Chunjing, WANG Ping. Study on the Optimal Time-use Composition of 24-hour Movement Behaviors for Obesity Prevention in College Students [J]. Chinese General Practice, 2026, 29(12): 1525-1532. |
| [15] | YAN Manli, ZHANG Baoqing, HUANG Lei, LI Xiang. A New Chapter in Obesity Treatment: Mechanisms and Clinical Research Progress of Multi-target Peptide Agonists [J]. Chinese General Practice, 2026, 29(12): 1511-1519. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||